Gene · 25962
Papers1,323
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,323
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Statement of Retraction: N6-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner. | Bioengineered | 2026 | 42821420 | PubTator, text mining | PubMed |
| KIAA1429 promotes chondrocyte senescence and ferroptosis in osteoarthritis progression by facilitating m6A-mediated downregulation of USP3. | Gen Physiol Biophys | 2026 | 42717782 | PubTator, text mining | PubMed |
| KIAA1429 knockdown alleviates osteosarcoma progression by destabilizing SLC7A11 mRNA via m6A methylation to promote ferroptosis. | Int J Oncol | 2026 | 42627048 | PubTator, text mining | PubMed |
| KIAA1429 promotes gallbladder cancer progression through m6A-dependent post-transcriptional modification of KIF20A. | Sci Rep | 2026 | 42437826 | PubTator, text mining | PubMed |
| m6A RNA methylation regulatory gene expression in response to ethanol and acetaldehyde exposure and withdrawal. | Environ Epigenet | 2026 | 41970606 | PubTator, text mining | PubMed |
| CancerHubs Data Explorer: a web application for investigating mutation-enriched protein interaction hubs in human cancers. | BioData Min | 2026 | 41913220 | PubTator, text mining | PubMed |
| KIAA1429 promotes clear cell renal cell carcinoma progression by regulating MYC mRNA stability. | iScience | 2026 | 41907423 | PubTator, text mining | PubMed |
| USP7 Drives Atherosclerosis by Promoting Ferroptosis in Vascular Endothelial Cells via the KIAA1429/NEAT1/CTCF Axis. | Biol Proced Online | 2026 | 41826832 | PubTator, text mining | PubMed |
| Identification of immune-related targets of N6-methyladenosine regulators in hepatocellular carcinoma via RNA-seq analysis. | Transl Cancer Res | 2026 | 41815123 | PubTator, text mining | PubMed |
| Differences in the expression profiles of m6A-related genes and the prognostic role in immunotherapy for lung adenocarcinoma patients. | Front Oncol | 2026 | 41809822 | PubTator, text mining | PubMed |
| The mechanism of Vicenin-2 in ameliorating skin photoaging: involvement of m6A-modified macrophage polarization. | Front Pharmacol | 2026 | 41800084 | PubTator, text mining | PubMed |
| Identification of FTO as a key m6A demethylase linking immune dysregulation to sepsis pathogenesis. | Front Immunol | 2026 | 41789088 | PubTator, text mining | PubMed |
| Uncovering mitochondrial dynamics-related genes as potential diagnostic biomarkers for acute myocardial infarction. | Front Cardiovasc Med | 2026 | 41768570 | PubTator, text mining | PubMed |
| N6-methyladenosine methylation in acute lung injury: Mechanisms and research progress. | J Intensive Med | 2026 | 41736779 | PubTator, text mining | PubMed |
| Mechanisms at the Intersection of lncRNA and m6A Biology. | Noncoding RNA | 2026 | 41718093 | PubTator, text mining | PubMed |
| The role of m6A RNA methyltransferase METTL3 in drug resistance mechanisms in acute myeloid leukemia. | Blood Res | 2026 | 41615563 | PubTator, text mining | PubMed |
| METTL16 Inhibits Lens Epithelial Cells Function in Diabetic Cataract via m6A-Modified DKK1-Mediated Wnt/β-Catenin Signaling. | Invest Ophthalmol Vis Sci | 2026 | 41533902 | PubTator, text mining | PubMed |
| KIAA1429 Stabilizes FAM84B mRNA to Enhance Colorectal Cancer Tumorigenesis via Wnt/β-Catenin Pathway. | Biochem Genet | 2026 | 41329451 | PubTator, text mining | PubMed |
Y10 phosphorylation of LDHA promotes the release of extracellular vesicle-derived circSEPT9 to enhance the chemoresistance of triple negative breast cancer cells via modulation of the miR-515-5p/KIAA1429 axis. | Drug Resist Updat | 2026 | 41237467 | PubTator, text mining | PubMed |
| Genetic regulators of neuronal survival across metabolic environments. | bioRxiv | 2025 | 41659455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25962/papers